Small but specialized Austin Clinical Research is a boutique medical research provider with a focus on Phase II-IV trials in asthma, allergies, hypertension, diabetes, COPD, osteoarthritis, obesity, and cardiovascular disorders. This suggests opportunities to engage larger sponsors seeking a nimble site for specific indications or early-phase expansion without the overhead of big CROs.

Limited headcount With 0-1 employees, the company may rely on external networks or partnerships to execute trials. Prospects for collaboration include offering full-service study management, patient recruitment assistance, and subcontracting arrangements to scale capacity quickly for sponsors who need a local or flexible partner.

Diverse study durations Studies range from two weeks to over a year with 6 to 200 participants per study, indicating capacity for both fast-turnaround pilot studies and longer, complex trials. This presents opportunities to tailor proposals around flexible timelines, patient enrollment efficiency, and staggered milestones for sponsors.

Tech stack footprint Current tools include WordPress, Google Analytics, Sentry, Office 365, Webflow, Google Tag Manager, Google Fonts, and Facebook. This shows basic digital presence and analytics potential; incentives exist to propose enhanced digital engagement, centralized trial management portals, patient recruitment marketing, and data capture improvements.

Revenue scale and positioning Revenue below $1M places Austin Clinical Research among smaller providers. This creates a sales angle for mid-market sponsors seeking cost-effective, high-touch site partnerships with potential for premium collaboration on scope, quality, and speed to market, while leveraging a lean governance model.